Targeting Mutant p53 by a SIRT1 Activator YK-3-237 Inhibits the Proliferation of Triple-Negative Breast Cancer Cells

Abstract excerpt

// Yong Weon Yi 1,* , Hyo Jin Kang 1,* , Hee Jeong Kim 1 , Yali Kong 3 , Milton L. Brown 3 and Insoo Bae 1,2,3 1 Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 2 Department of Radiation Medicine, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 3 Center for Drug Discovery, Georgetown University, Washington, DC * These authors...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Autophagy in Disease and Therapy
• Share to Sirtuins and Resveratrol in Medicine
• Share to Tea Polyphenols and Effects